Top 5 Stocks to Buy Now
→ Gold Will Hit $4,900 (From Investors Alley) (Ad)tc pixel Free ACET Stock Alerts

Adicet Bio (ACET) Competitors

Adicet Bio logo
$7.90 -0.35 (-4.24%)
Closing price 06/25/2026 04:00 PM Eastern
Extended Trading
$8.05 +0.15 (+1.87%)
As of 06/25/2026 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

ACET vs. ADMA, URI, GWW, FAST, and WCC

Should you buy Adicet Bio stock or one of its competitors? MarketBeat compares Adicet Bio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Adicet Bio include ADMA Biologics (ADMA), United Rentals (URI), W.W. Grainger (GWW), Fastenal (FAST), and WESCO International (WCC).

How does Adicet Bio compare to ADMA Biologics?

Adicet Bio (NASDAQ:ACET) and ADMA Biologics (NASDAQ:ADMA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

In the previous week, ADMA Biologics had 33 more articles in the media than Adicet Bio. MarketBeat recorded 34 mentions for ADMA Biologics and 1 mentions for Adicet Bio. ADMA Biologics' average media sentiment score of 0.06 beat Adicet Bio's score of -0.30 indicating that ADMA Biologics is being referred to more favorably in the news media.

Company Overall Sentiment
Adicet Bio Neutral
ADMA Biologics Neutral

Adicet Bio currently has a consensus price target of $48.80, suggesting a potential upside of 517.72%. ADMA Biologics has a consensus price target of $19.67, suggesting a potential upside of 125.54%. Given Adicet Bio's stronger consensus rating and higher probable upside, analysts clearly believe Adicet Bio is more favorable than ADMA Biologics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
ADMA Biologics
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

ADMA Biologics has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than ADMA Biologics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adicet BioN/AN/A-$116.80M-$14.90N/A
ADMA Biologics$510.17M3.96$146.93M$0.6812.82

Adicet Bio has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market. Comparatively, ADMA Biologics has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market.

83.9% of Adicet Bio shares are held by institutional investors. Comparatively, 75.7% of ADMA Biologics shares are held by institutional investors. 3.4% of Adicet Bio shares are held by insiders. Comparatively, 3.9% of ADMA Biologics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

ADMA Biologics has a net margin of 32.43% compared to Adicet Bio's net margin of 0.00%. ADMA Biologics' return on equity of 39.98% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Adicet BioN/A -80.35% -65.44%
ADMA Biologics 32.43%39.98%28.08%

Summary

ADMA Biologics beats Adicet Bio on 10 of the 16 factors compared between the two stocks.

How does Adicet Bio compare to United Rentals?

Adicet Bio (NASDAQ:ACET) and United Rentals (NYSE:URI) are both trading companies & distributors companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

Adicet Bio has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market. Comparatively, United Rentals has a beta of 1.81, suggesting that its share price is 81% more volatile than the broader market.

83.9% of Adicet Bio shares are owned by institutional investors. Comparatively, 96.3% of United Rentals shares are owned by institutional investors. 3.4% of Adicet Bio shares are owned by company insiders. Comparatively, 0.5% of United Rentals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Adicet Bio presently has a consensus target price of $48.80, suggesting a potential upside of 517.72%. United Rentals has a consensus target price of $1,070.50, suggesting a potential downside of 6.19%. Given Adicet Bio's higher probable upside, equities analysts plainly believe Adicet Bio is more favorable than United Rentals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
United Rentals
1 Sell rating(s)
1 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.81

United Rentals has a net margin of 15.32% compared to Adicet Bio's net margin of 0.00%. United Rentals' return on equity of 30.56% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Adicet BioN/A -80.35% -65.44%
United Rentals 15.32%30.56%9.23%

In the previous week, United Rentals had 24 more articles in the media than Adicet Bio. MarketBeat recorded 25 mentions for United Rentals and 1 mentions for Adicet Bio. United Rentals' average media sentiment score of 1.53 beat Adicet Bio's score of -0.30 indicating that United Rentals is being referred to more favorably in the news media.

Company Overall Sentiment
Adicet Bio Neutral
United Rentals Very Positive

United Rentals has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than United Rentals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adicet BioN/AN/A-$116.80M-$14.90N/A
United Rentals$16.10B4.44$2.49B$39.2029.11

Summary

United Rentals beats Adicet Bio on 13 of the 16 factors compared between the two stocks.

How does Adicet Bio compare to W.W. Grainger?

Adicet Bio (NASDAQ:ACET) and W.W. Grainger (NYSE:GWW) are both trading companies & distributors companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

In the previous week, W.W. Grainger had 16 more articles in the media than Adicet Bio. MarketBeat recorded 17 mentions for W.W. Grainger and 1 mentions for Adicet Bio. W.W. Grainger's average media sentiment score of 1.14 beat Adicet Bio's score of -0.30 indicating that W.W. Grainger is being referred to more favorably in the news media.

Company Overall Sentiment
Adicet Bio Neutral
W.W. Grainger Positive

W.W. Grainger has a net margin of 9.70% compared to Adicet Bio's net margin of 0.00%. W.W. Grainger's return on equity of 47.87% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Adicet BioN/A -80.35% -65.44%
W.W. Grainger 9.70%47.87%21.84%

83.9% of Adicet Bio shares are owned by institutional investors. Comparatively, 80.7% of W.W. Grainger shares are owned by institutional investors. 3.4% of Adicet Bio shares are owned by company insiders. Comparatively, 6.3% of W.W. Grainger shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Adicet Bio presently has a consensus price target of $48.80, indicating a potential upside of 517.72%. W.W. Grainger has a consensus price target of $1,216.44, indicating a potential downside of 11.31%. Given Adicet Bio's stronger consensus rating and higher probable upside, equities research analysts plainly believe Adicet Bio is more favorable than W.W. Grainger.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
W.W. Grainger
1 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20

W.W. Grainger has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than W.W. Grainger, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adicet BioN/AN/A-$116.80M-$14.90N/A
W.W. Grainger$17.94B3.61$1.71B$37.1836.89

Adicet Bio has a beta of 1.56, meaning that its stock price is 56% more volatile than the broader market. Comparatively, W.W. Grainger has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market.

Summary

W.W. Grainger beats Adicet Bio on 10 of the 16 factors compared between the two stocks.

How does Adicet Bio compare to Fastenal?

Fastenal (NASDAQ:FAST) and Adicet Bio (NASDAQ:ACET) are both trading companies & distributors companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

81.4% of Fastenal shares are held by institutional investors. Comparatively, 83.9% of Adicet Bio shares are held by institutional investors. 0.3% of Fastenal shares are held by company insiders. Comparatively, 3.4% of Adicet Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Fastenal has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than Fastenal, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fastenal$8.20B6.57$1.26B$1.1441.16
Adicet BioN/AN/A-$116.80M-$14.90N/A

In the previous week, Fastenal had 7 more articles in the media than Adicet Bio. MarketBeat recorded 8 mentions for Fastenal and 1 mentions for Adicet Bio. Fastenal's average media sentiment score of 0.13 beat Adicet Bio's score of -0.30 indicating that Fastenal is being referred to more favorably in the media.

Company Overall Sentiment
Fastenal Neutral
Adicet Bio Neutral

Fastenal has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market. Comparatively, Adicet Bio has a beta of 1.56, meaning that its stock price is 56% more volatile than the broader market.

Fastenal has a net margin of 15.39% compared to Adicet Bio's net margin of 0.00%. Fastenal's return on equity of 33.25% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Fastenal15.39% 33.25% 25.49%
Adicet Bio N/A -80.35%-65.44%

Fastenal presently has a consensus price target of $49.57, indicating a potential upside of 5.65%. Adicet Bio has a consensus price target of $48.80, indicating a potential upside of 517.72%. Given Adicet Bio's stronger consensus rating and higher probable upside, analysts clearly believe Adicet Bio is more favorable than Fastenal.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fastenal
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

Summary

Fastenal beats Adicet Bio on 9 of the 15 factors compared between the two stocks.

How does Adicet Bio compare to WESCO International?

WESCO International (NYSE:WCC) and Adicet Bio (NASDAQ:ACET) are both trading companies & distributors companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, media sentiment and valuation.

93.8% of WESCO International shares are held by institutional investors. Comparatively, 83.9% of Adicet Bio shares are held by institutional investors. 2.6% of WESCO International shares are held by company insiders. Comparatively, 3.4% of Adicet Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

WESCO International has a beta of 1.53, indicating that its stock price is 53% more volatile than the broader market. Comparatively, Adicet Bio has a beta of 1.56, indicating that its stock price is 56% more volatile than the broader market.

In the previous week, WESCO International had 5 more articles in the media than Adicet Bio. MarketBeat recorded 6 mentions for WESCO International and 1 mentions for Adicet Bio. WESCO International's average media sentiment score of 1.32 beat Adicet Bio's score of -0.30 indicating that WESCO International is being referred to more favorably in the media.

Company Overall Sentiment
WESCO International Positive
Adicet Bio Neutral

WESCO International currently has a consensus price target of $334.56, suggesting a potential downside of 6.15%. Adicet Bio has a consensus price target of $48.80, suggesting a potential upside of 517.72%. Given Adicet Bio's higher possible upside, analysts clearly believe Adicet Bio is more favorable than WESCO International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WESCO International
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.00
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

WESCO International has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than WESCO International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WESCO International$23.51B0.74$640.20M$14.0725.34
Adicet BioN/AN/A-$116.80M-$14.90N/A

WESCO International has a net margin of 2.79% compared to Adicet Bio's net margin of 0.00%. WESCO International's return on equity of 13.82% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
WESCO International2.79% 13.82% 4.12%
Adicet Bio N/A -80.35%-65.44%

Summary

WESCO International beats Adicet Bio on 12 of the 15 factors compared between the two stocks.

Get Adicet Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACET vs. The Competition

Export
MetricAdicet BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$77.12M$3.52B$6.61B$12.27B
Dividend YieldN/A2.28%2.67%5.87%
P/E Ratio-0.5321.1226.0223.97
Price / SalesN/A329.07542.89101.46
Price / CashN/A134.9146.3353.91
Price / Book0.488.0410.516.32
Net Income-$116.80M$23.91M$3.57B$337.22M
7 Day Performance-2.47%1.36%0.79%-1.24%
1 Month Performance-5.16%0.77%0.21%-0.63%
1 Year Performance-26.37%56.92%30.81%27.95%

Adicet Bio Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACET
Adicet Bio
2.9638 of 5 stars		$7.90
-4.2%		$48.80
+517.7%		-25.0%$77.12MN/AN/A90
ADMA
ADMA Biologics
4.3903 of 5 stars		$8.57
+3.1%		$19.67
+129.5%		-50.5%$1.93B$509.86M12.60530
URI
United Rentals
3.8006 of 5 stars		$1,092.73
+1.5%		$1,045.81
-4.3%		+54.8%$67.46B$16.10B27.8828,500
GWW
W.W. Grainger
3.56 of 5 stars		$1,343.73
-1.6%		$1,217.00
-9.4%		+33.9%$64.47B$18.38B36.1422,100
FAST
Fastenal
3.505 of 5 stars		$46.12
+0.5%		$49.57
+7.5%		+14.1%$52.68B$8.20B40.4624,489

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ACET) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
The EPA just put a kill switch on Elon’s empire
A federal EPA permit expires January 2, 2027 - and if Elon Musk's Colossus supercomputer loses power that day,...
Behind the Markets | Sponsoredtc pixel
Millionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.
Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...
Brownstone Research | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely, LLC | Sponsoredtc pixel
Grab it and keep it
Simple Options Trading For Beginners is currently available as a free download - a guide normally priced at $2...
Profits Run | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel